U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07300956) titled 'Treating Young Children With Attention Deficit Hyperactivity Disorder' on Dec. 22.
Brief Summary: This project will evaluate the effectiveness of Methylphenidate versus Guanfacine in treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 3 through 5 years (inclusive), as measured by clinician rating of global improvement.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Attention-Deficit/Hyperactivity Disorder (ADHD)
Intervention:
DRUG: Guanfacine (GUA)
After engaging in behavioral therapy, participants randomized into this group participants will be prescribed Guanfacine. Each child's pre...